Needlestick injuries in European nurses in diabetes

Diabetes and Metabolism

Volumn 38, Issue SUPPL. 1, 2012, Pages S9-

  Costigliola, V ^a   Frid, A ^b   Letondeur, C ^c   Strauss, K ^d  

^a European Medical Association   (Belgium)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

^c BD Diabetes Care   (France)

^d BD Diabetes Care   (Belgium)

Author keywords

Bloodborne pathogens; EU directive; Fingerstick injury; Health care worker safety; Hepatitis B; Hepatitis C; HIV; Insulin injection; Muco cutaneous exposure; Revue

Indexed keywords

EXENDIN 4; LIRAGLUTIDE;

ARTICLE; DIABETES MELLITUS; DISEASE TRANSMISSION; HEALTH SURVEY; HUMAN; INFECTION CONTROL; NEEDLESTICK INJURY; NURSE; OCCUPATIONAL SAFETY; QUESTIONNAIRE; RISK FACTOR; RUSSIAN FEDERATION; SELF INJECTION; WESTERN EUROPE;

EID: 84856507996     PISSN: 12623636     EISSN: 18781780     Source Type: Journal    
DOI: 10.1016/S1262-3636(12)70976-X     Document Type: Article

References (31)

1. European Parliament, Preventing needle-stick injuries in the health sector, 11th February 2010, http://www.europarl.europa.eu/sides/getDoc.do?pubRef=-//EP//TEXT+IM-PRESS+20100210IPR68824+0+DOC+XML+V0//EN.
2. Wittmann A., Köver J., Hofmann F., Kralj N. übertragene Blutvolumina nach Nadelstichverletzungen an s.c. Kanülen. Dokumentations-CDROM über 49. Jahrestagung der DGAUM 2009, 382-384.
3. Risks of Dried Blood, Center for Disease Control 1995, Atlanta, USA.
4. Prüss-üstün A, Rapiti E, Hutin Y. Global burden of disease from sharps injuries to health-care workers; Environmental Burden of Disease Series, No. 3; World Health Organization Protection of the Human Environment Geneva 2003. Table 9, Hepatitis B vaccine coverage among health-care workers.
5. Council Directive 2010/32/EU, Official Journal of the European Union, L134/71, uri=OJ :L: 2010:134:0066:0072:EN:PDF. http://eurlex.europa.eu/LexUriServ/LexUriServ.do%3F.
6. EU Commission for Employment, Social Affairs and Inclusion, New legislation to reduce injuries for 3.5 million healthcare workers in Europe, 8th March 2010.
7. Article 3.2 says that where risk cannot be eliminated the employer shall take appropriate measures to minimise the risks. Appropriate measures to minimise the risks would include the provision by employers of safer needle devices. (Cf. NHS Employers, Implementation advice on sharps agreement, 12th October 2010) The Directive specifically requires: 'eliminating the unnecessary use of sharps by implementing changes in practice and on the basis of the results of the risk assessment, providing medical devices incorporating safety-engineered protection mechanisms.' Council Directive 2010/32/EU, Official Journal of the European Union, L134/71 and Council Directive 2010/32/EU, Official Journal of the European Union, L134/69.
8. Het verminderen van prikaccidenten door inzet van veiligheidssystemen, Dutch Nationaal Hepatitis Centrum, March 2009.
9. Perry J, Parker G, Jagger J. EPINet Report 2004. Percutaneous Injury Rate. International Healthcare Worker Safety Center. August 2007.
10. Watterson L. Sharp Thinking. Nursing Standard 2005, 20:20-22.
11. Kiss P., De Meester M., Braeckman L. Needle stick injuries in nursing homes: The prominent role of insulin pens. Infect Control Hosp Epidemiol 2008, 29:1192-1194.
12. Lee J.M., Botteman M.F., Nicklasson L., Cobden D., Pashos C.L. Needlestick injury in acute care nurses caring for patients with diabetes mellitus: a retrospective study. Curr Med Res Opin 2005, 21:741-747.
13. Adams D., Elliott T.S.J. Impact of safety needle devices on occupationally acquired needle stick injuries: a four-year prospective study. J Hosp Infect 2006, 64:50-55.
14. Tarantola A., Golliot F., Astagneau P., Fleury L., Brucker G., Bouvet E. CCLIN Paris-Nord Blood and Body Fluids (BBF) Exposure Surveillance Taskforce. Four-year surveillance from the Northern France network. Am J Infect Control 2003, 31:357-363.
15. Cullen B.L., Genasi F., Symington I., Bagg J., McCreaddie M., Taylor A., et al. Potential for reported needle stick injury prevention among healthcare workers in NHS Scotland through safety device usage and improvement of guideline adherence: an expert panel assessment. J Hosp Infect 2006, 63:445-451.
16. Mendelson MH, Lin-Chen BY, Finkelstein-Blond L, Bailey E, Kogan G. Evaluation of a Safety IV Catheter (IVC) (Becton Dickinson, INSYTE™ AUTOGUARD™): Final Report Eleventh Annual Scientific Meeting Society for Healthcare Epidemiology of America, 2001 SHEA, Toronto, Canada.
17. Louis N., Vela G., Groupe, Projet évaluation de l'efficacité d'une mesure de prévention desaccidents d'exposition au sang au cours du prélèvement de sang veineux. Bull Epidemiol Hebd 2002, 51:260-261.
18. Demir M., Serin E., Göktürk S., Ozturk N.A., Kulaksizoglu S., Ylmaz U. The prevalence of occult Hepatitis B virus infection in type 2 diabetes mellitus patients. Eur J Gastroenterol Hepatol 2008, 20:668-673.
19. Michel M.L., Tiollais P. Hepatitis B vaccines: protective efficacy and therapeutic potential. Pathol Biol (Paris) 2010, 58:288-295.
20. Prüss-üstün A, Rapiti E, Hutin Y. Global burden of disease from sharps injuries to health-care workers; Environmental Burden of Disease Series, No. 3; World Health Organization Protection of the Human Environment Geneva 2003. Table 9, Hepatitis B vaccine coverage among health-care workers.
21. De Schryver A., Claesen B., Meheus A., van Sprundel M., François G. European survey of Hepatitis B vaccination policies for healthcare workers. Eur J Public Health 2011, 2:338-343.
22. Simó R., Hernández C., Genescà J., Jardí R., Mesa J. High prevalence of Hepatitis C virus infection in diabetic patients. Diabetes Care 1996, 19:998-1000.
23. Mondy K., Overton E.T., Grubb J., Tong S., Seyfried W., Powderly W., Yarasheski K. Metabolic syndrome in HIV-infected patients from an urban, midwestern US outpatient population. Clin Infect Dis 2007, 44:726-734.
24. Le Floch J.P., Herbreteau C., Lange F., Perlemuter L. Biologic material in needles and cartridges after insulin injection with a pen in diabetic patients. Diabetes Care 1998, 21:1502-1504.
25. See, for instance, Nursing Times, Why we must stop needlesick injuries, 3 October 2006.
26. Adams D., Elliott T.S. Impact of safety needle devices on occupationally acquired needlestick injuries: a four-year prospective study. J Hosp Infect 2006, 64:50-55.
27. Jagger J., Perry J., Gomaa A., Phillips E.K. The impact of U.S. policies to protect healthcare workers from bloodborne pathogens: The critical role of safety-engineered devices. J Infect Public Health 2008, 1:62-71.
28. Armadans Gil L., Fernandez Cano M.I., Albero Andres I., Angles Mellado M.L., Sanchez Garcia J.M., Campins Marti M., Vaque Rafart J. Safetyengineered devices to prevent percutaneous injuries: cost-effectiveness analysis on prevention of high-risk exposure. Gac Sanit (Spanish) 2006, 20:374-381.
29. Glenngård A.H., Persson U. Costs associated with sharps injuries in the Swedish health care setting and potential cost savings from needle-stick prevention devices with needle and syringe. Scand J Infect Dis 2009, 41:296-302.
30. NHS Scotland, Needlestick Injuries; Sharpen your Awareness, Annex 3, Safer Devices Cost Benefit Assessment. http://www.sehd.scot.nhs/.uk/publications/nisa/nisa-13.htm.
31. Council Directive 2010/32/EU, Official Journal of the European Union, L134/71, http://eurlex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2010:134:0066:0072:EN:PDF.